Vaccines for the prevention of diseases caused by potential bioweapons
- 30 April 2004
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 111 (1), 1-15
- https://doi.org/10.1016/j.clim.2003.09.010
Abstract
The development of vaccines and implementation of vaccination programs are among the most important medical contributions to humanity. To date, vaccination has reduced morbidity and mortality from infectious diseases more than any other specific medical intervention. The intentional use of bioweapons against civilians (bioterrorism), recently highlighted by events around the world, has fueled interest in the development of vaccines for potential microbial agents of bioterror. This review discusses the microbial agents that are considered to pose the greatest risk to the public, the diseases associated with them, and the vaccines that are available for their prevention. The paucity of such vaccines and uncertainty regarding mechanisms of vaccine efficacy and the microbial antigens that elicit protection underscore the need for continued study of host–microbe interaction and the immune response to potential agents of bioterror for the development of new vaccines and immune-based therapies to combat their potential to harm the public.Keywords
This publication has 96 references indexed in Scilit:
- The damage-response framework of microbial pathogenesisNature Reviews Microbiology, 2003
- Diagnosis and Management of SmallpoxNew England Journal of Medicine, 2002
- Clinical Responses to Undiluted and Diluted Smallpox VaccineNew England Journal of Medicine, 2002
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in MiceInfection and Immunity, 2002
- Recognition and Management of Anthrax — An UpdateNew England Journal of Medicine, 2001
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- AnthraxNew England Journal of Medicine, 1999
- Multidrug Resistance inYersinia pestisMediated by a Transferable PlasmidNew England Journal of Medicine, 1997
- A new look at typhoid vaccination. Information for the practicing physicianPublished by American Medical Association (AMA) ,1991